The Janus serum bank and biomarkers of cancer

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The Janus serum bank, established in 1973, contains sera stored at -25 degrees collected from 330,000 originally healthy individuals. The number of cancer cases have increased from zero in 1973 to more than 50,000 in 2005, including invasive and non-invasive cancers. Information on cases have been obtained by coupling the Janus file against the Norwegian Cancer Registry. The sera have been used in over 70 different cancers research projects, usually in case-control studies and in collaboration with national and international research groups. The type of biomarker analysed include antibodies against Chlamydia, CMV, Epstein Barr virus, HPV and Helicobacter pylori. Leptin, long chain fatty acids, androgens and other hormones, vitamins as well as environmental toxins such as organochlorines are other types of cancer biomarkers investigated. Mutation analyses (BRCA-1 etc) have been possible using PCR and the trace amounts of DNA remaining in the sera.

Cite

CITATION STYLE

APA

Gislefoss, R., & Jellum, E. (2006, March). The Janus serum bank and biomarkers of cancer. Norsk Epidemiologi. https://doi.org/10.5324/nje.v16i1.206

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free